tiprankstipranks
VA to widely cover new Alzheimer’s treatment from Eisai and Biogen, STAT says
The Fly

VA to widely cover new Alzheimer’s treatment from Eisai and Biogen, STAT says

The Veterans Health Administration, in "an unexpected move," announced Monday that it will widely cover a new Alzheimer’s treatment for veterans who meet agency criteria for using Leqembi, which is being marketed by Eisai (ESALY) and partner Biogen (BIIB), reported STAT’s Ed Silverman. Reference Link

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on BIIB:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles